Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Conroy

Showing results (61-70 of 138) with videos related to

Pageof 14
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2003
An open phase I study assessing the feasibility of the triple combination: oxaliplatin plus irinotecan plus leucovorin/ 5-fluorouracil every 2 weeks in patients with advanced solid tumorsM Ychou, T Conroy, J F Seitz, et al.
Cancer|October 1, 1993
Simplified chronomodulated continuous infusion of floxuridine in patients with metastatic renal cell carcinomaT Conroy, L Geoffrois, F Guillemin, et al.
European Journal of Cancer (Oxford, England : 1990)|September 30, 2004
French version of FACT-G: validation and comparison with other cancer-specific instrumentsT Conroy, M Mercier, J Bonneterre, et al.
British Journal of Cancer|May 18, 2001
Carcinoma of the colonA Adenis, T Conroy, P Lasser, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|November 1, 1990
[Abnormal tricuspid flow in carcinoid heart disease. A case report]C Selton-Suty, Y Juillière, J Anconina, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 18, 2009
Surrogate end points for overall survival and local control in neoadjuvant rectal cancer trials: statistical evaluation based on the FFCD 9203 trialN Methy, L Bedenne, T Conroy, et al.
International Journal of Radiation Oncology, Biology, Physics|December 30, 1998
Prognostic implications of downstaging following preoperative radiation therapy for operable T3-T4 rectal cancerM C Kaminsky-Forrett, T Conroy, E Luporsi, et al.
Anticancer Research|November 1, 1994
Clinical randomized study of 5FU monitoring versus standard dose in patients with head and neck cancer: preliminary resultsR Fety, F Rolland, M Barberi-Heyob, et al.
Bulletin Du Cancer|January 1, 1993
[Clinical presentation and prognostic factors in the diagnosis of bone metastases. Apropos of a series of 578 cases]T Conroy, C Platini, P Troufléau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 7, 2023
Moving toward precision oncology centers V2.0S Dogan, P-H Cournède, E Solary, et al.
Pageof 14

Showing results (61-70 of 138) with videos related to

Sort By:
Pageof 14
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2003
An open phase I study assessing the feasibility of the triple combination: oxaliplatin plus irinotecan plus leucovorin/ 5-fluorouracil every 2 weeks in patients with advanced solid tumorsM Ychou, T Conroy, J F Seitz, et al.
Cancer|October 1, 1993
Simplified chronomodulated continuous infusion of floxuridine in patients with metastatic renal cell carcinomaT Conroy, L Geoffrois, F Guillemin, et al.
European Journal of Cancer (Oxford, England : 1990)|September 30, 2004
French version of FACT-G: validation and comparison with other cancer-specific instrumentsT Conroy, M Mercier, J Bonneterre, et al.
British Journal of Cancer|May 18, 2001
Carcinoma of the colonA Adenis, T Conroy, P Lasser, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|November 1, 1990
[Abnormal tricuspid flow in carcinoid heart disease. A case report]C Selton-Suty, Y Juillière, J Anconina, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 18, 2009
Surrogate end points for overall survival and local control in neoadjuvant rectal cancer trials: statistical evaluation based on the FFCD 9203 trialN Methy, L Bedenne, T Conroy, et al.
International Journal of Radiation Oncology, Biology, Physics|December 30, 1998
Prognostic implications of downstaging following preoperative radiation therapy for operable T3-T4 rectal cancerM C Kaminsky-Forrett, T Conroy, E Luporsi, et al.
Anticancer Research|November 1, 1994
Clinical randomized study of 5FU monitoring versus standard dose in patients with head and neck cancer: preliminary resultsR Fety, F Rolland, M Barberi-Heyob, et al.
Bulletin Du Cancer|January 1, 1993
[Clinical presentation and prognostic factors in the diagnosis of bone metastases. Apropos of a series of 578 cases]T Conroy, C Platini, P Troufléau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 7, 2023
Moving toward precision oncology centers V2.0S Dogan, P-H Cournède, E Solary, et al.
Pageof 14